-+ 0.00%
-+ 0.00%
-+ 0.00%

CEREVANCE : SOLENGEPRAS 150MG REDUCES DAILY OFF TIME BY 0.61 HOURS VS PLACEBO AT WEEK 12 IN PHASE 3 ARISE TRIAL

Reuters·10/07/2026 12:03:04